We deliver a seamless transition from small-scale laboratory pilot studies to high-volume screening of large experimental research cohorts with consistent analytical performance.
Creative Biolabs offers an analytical platform for the isolation, quantification, and multi-omic profiling of CSC-derived extracellular vesicles. We provide researchers with high-purity exosomal fractions and detailed molecular signatures, including transcriptomic and phosphoproteomic data. By utilizing our service, clients can expect to gain a deeper understanding of the "infectious" communication between malignant cells and their microenvironment, enabling the identification of novel drug targets and the mapping of tumor resistance mechanisms with high sensitivity.
Exosomes are critical mediators of the "seed and soil" hypothesis, serving as the primary vehicle for Cancer Stem Cells to prepare distant metastatic niches in research models. Recent scientific literature confirms that these vesicles carry a concentrated payload of phosphorylated proteins and non-coding RNAs that reflect the parent cell's state more accurately than apoptotic debris. Creative Biolabs leverages these biological insights, utilizing specialized analysis and optical nanobiosensors to provide a high-fidelity map of tumor progression and therapeutic resistance for scientific discovery.
Fig.1 Biomarkers are used to confirm EXOs. 1
We deliver a seamless transition from small-scale laboratory pilot studies to high-volume screening of large experimental research cohorts with consistent analytical performance.
Our team builds bespoke biomarker panels optimized to detect rare miRNAs or surface proteins that align specifically with your proprietary targets.
We utilize Quality-by-Design principles and advanced analytical techniques to ensure rigorous reproducibility and precision during exosome isolation across numerous samples.
Our batch and continuous-mode acoustofluidic separation technologies maximize the recovery of high-purity CSC vesicles while effectively eliminating background molecular noise.
Creative Biolabs bridges the gap between advanced material science and cellular biology to provide a unique perspective on tumor microenvironment signaling networks.
We focus on tracking the cellular communication that drives premetastatic development, allowing researchers to observe how malignant cells influence healthy experimental tissues.
Our platform identifies low-abundance markers that remain undetectable via standard methods, providing a much higher resolution for your early-stage research data.
Our established workflows strictly adhere to international extracellular vesicle guidelines, ensuring that your results are verified, reliable, and publication-ready.
Reach out to our experts to explore how our specialized CSC exosome detection can be integrated into your specific research framework.
Unlike rare and fragile CTCs, exosomes are abundant and highly stable due to their lipid bilayer. Our service provides a consistent molecular snapshot of the tumor signaling network.
Yes, we utilize a specialized dual-affinity capture method targeting general markers and specific stemness markers to enrich these subpopulations, ensuring highly precise and relevant research data analysis.
Utilizing next-generation sequencing to identify genetic variants and driver mutations within complex tumor research models for therapeutic target discovery.
Learn More →High-throughput screening of gene expression patterns and chromosomal abnormalities to provide rapid, large-scale molecular characterization of research tumor samples.
Learn More →Creative Biolabs provides a sophisticated platform for decoding the communication network of cancer stem cells in research. From ultra-sensitive nanobiosensors to AI-driven metastatic prediction, we offer the tools necessary to overcome the limitations of current analytical methods.
Connect our team to receive tailored guidance on sample preparation, analytical design, and the integration of our multi-omic findings into your ongoing research pipeline.
Reference